A woman in Singapore lost her eyesight after receiving dermal fillers, prompting an investigation by the Health Sciences Authority (HSA). Dermal fillers carry a known risk of causing blood vessel blockages that can result in blindness. The case involved a non-HA filler with poly-D-L-lactic acid (PDLLA) as its main ingredient, which cannot be reversed. The global hyaluronic acid market is projected to reach a value of USD 14.84 billion by 2030, driven by the increasing interest in injectable hyaluronic acid and the growing demand for minimally invasive cosmetic procedures.

Dermal Fillers and Blindness